Abstract
The normal development of the male reproductive system can be divided into five phases: fetal, neonatal, childhood, puberty and adulthood. Childhood/peripuberty has yet been relatively little studied. Chemical insults during the peripubertal phase may result in adverse consequences that may be already visible during puberty as well as during later adult life. This occurs because endocrine disruptors often interfere in the developmental programming. The most important is to note that children are not just little adults and should be particularly investigated. The aim of this review is to discuss the recent literature (2000-2013) on male reproductive aspects in prepubertal toxicity assays, focusing on experimental in vivo studies, establishing a comparative analysis between the design, endpoints, results and consequent conclusion. The studies discussed in the present review were selected based on the period of exposure. Only studies with post-lactational exposures were included. 33 papers were included using rats, mice, rabbits or pigs as experimental model. There is a relative scarcity of studies investigating animals in development and thus an urgent need for further studies in order to evaluate the possible persistent effects on fertility and other reproductive parameters at adulthood. Another point is the lack of studies with chemical mixtures, an imminent problem in modern society. It is vital to consider the refinement of alternative methods and the experimental designs and endpoints to improve the scientific knowledge in this area.
Keywords: Peripuberty, male, reproductive toxicology.
Current Pharmaceutical Design
Title:The Male Peripubertal Phase as a Developmental Window for Reproductive Toxicology Studies
Volume: 20 Issue: 34
Author(s): Juliana Elaine Perobelli
Affiliation:
Keywords: Peripuberty, male, reproductive toxicology.
Abstract: The normal development of the male reproductive system can be divided into five phases: fetal, neonatal, childhood, puberty and adulthood. Childhood/peripuberty has yet been relatively little studied. Chemical insults during the peripubertal phase may result in adverse consequences that may be already visible during puberty as well as during later adult life. This occurs because endocrine disruptors often interfere in the developmental programming. The most important is to note that children are not just little adults and should be particularly investigated. The aim of this review is to discuss the recent literature (2000-2013) on male reproductive aspects in prepubertal toxicity assays, focusing on experimental in vivo studies, establishing a comparative analysis between the design, endpoints, results and consequent conclusion. The studies discussed in the present review were selected based on the period of exposure. Only studies with post-lactational exposures were included. 33 papers were included using rats, mice, rabbits or pigs as experimental model. There is a relative scarcity of studies investigating animals in development and thus an urgent need for further studies in order to evaluate the possible persistent effects on fertility and other reproductive parameters at adulthood. Another point is the lack of studies with chemical mixtures, an imminent problem in modern society. It is vital to consider the refinement of alternative methods and the experimental designs and endpoints to improve the scientific knowledge in this area.
Export Options
About this article
Cite this article as:
Perobelli Elaine Juliana, The Male Peripubertal Phase as a Developmental Window for Reproductive Toxicology Studies, Current Pharmaceutical Design 2014; 20 (34) . https://dx.doi.org/10.2174/1381612820666140205150059
DOI https://dx.doi.org/10.2174/1381612820666140205150059 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypergonadotropic Hypogonadism: Management of Infertility
Current Pharmaceutical Design Female Infertility and Assisted Reproduction: Impact of Oxidative Stress-- An Update
Current Women`s Health Reviews Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer
Current Molecular Medicine Melatonin and Male Reproductive Health: Relevance of Darkness and Antioxidant Properties
Current Molecular Medicine The Clinical Characteristics and Survival Profiles of Wilms Tumor in the United Arab Emirates: A Single-center Retrospective Analysis
New Emirates Medical Journal Unravelling the Power of Omics for the Infertile Aging Male
Current Pharmaceutical Design Subject Index Volume 2
Current Pediatric Reviews Therapeutic Effects of Micronutrient Supplements on Sperm Parameters: Fact or Fiction?
Current Pharmaceutical Design Cutaneous Complications of Anderson-Fabry Disease
Current Pharmaceutical Design The Mechanisms Involved in Obesity-Induced Male Infertility
Current Diabetes Reviews The Fluctuations of Melatonin and Copeptin Levels in Blood Serum During Surgical Stress Regarding the Pediatric Population
Current Pediatric Reviews Current Guidelines and Strategies in Management of Renal Vein Thrombosis
Current Pediatric Reviews Contribution of Transcriptome to Elucidate the Biology of Plasmodium spp
Current Topics in Medicinal Chemistry Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry An Evidence-Based Review of Off-Label Uses of Polidocanol
Current Clinical Pharmacology Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Testicular Cell Junction: A Novel Target for Male Contraception
Current Medicinal Chemistry Targeting Post-Ejaculation Sperm for Value-Added Contraception
Current Molecular Pharmacology Redox Regulation of Fertility in Aging Male and the Role of Antioxidants: A Savior or Stressor
Current Pharmaceutical Design Effectiveness of Gonadotropin Administration for Spermatogenesis Induction in Hypogonadotropic Hypogonadism: A Possible Role of Androgen Receptor CAG Repeat Polymorphism and Therapeutic Measures
Endocrine, Metabolic & Immune Disorders - Drug Targets